Editors of some of the most widely read and respected international medical journals have significantly revised their uniform requirements for manuscript submission (JAMA.1998;280:2035). The revision, by members of the International Committee of Medical Journal Editors, is intended to alleviate authors' concerns that reporting a public health hazard or major therapeutic advance directly to the FDA or other government agency or to the media may jeopardize subsequent medical journal publication of an article or letter to the editor on the same topic. The revision states that such reporting may be warranted "when the paper or letter describes major therapeutic advances or public health hazards such as serious adverse effects of drugs, vaccines, other biological products, or medical devices, or reportable diseases." It states that this reporting should not jeopardize publication but should be discussed with and agreed on by the journal editor in advance.
Nightingale SL. Journal Editors Act to Enhance Reporting of Public Health Hazards. JAMA. 1999;281(5):408. doi:10.1001/jama.281.5.408-JFD90000-3-1